Alan J. Russell, Chief Scientific Officer at Edgewise Therapeutics, Inc. (EWTX), sold 17,230 shares at $30.02 ($517K) on 2025-02-05, disclosed to the SEC on 2025-02-07.
Scheduled sale ($517k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.02 | 8,015 | $241K | 46.5% |
| 2 | $30.02 | 8,015 | $241K | 46.5% |
| 3 | $30.13 | 1,200 | $36K | 7.0% |
| Total | $30.03 avg | 17,230 | $517K | 100% |
| Filing → |
| EWTX | SELL | 2025-11-13 | $2.1M | — | Filing → |
| EWTX | SELL | 2025-08-28 | $1.5M | — | Filing → |
| EWTX | SELL | 2025-08-14 | $26K | — | Filing → |